Type 2 Diabetes Risks
Referred to as non-insulin dependent diabetes, type 2 diabetes affects 90-95% of the total diabetes population. Words like ‘epidemic' and ‘worldwide crises' are often used when talking about it however, diabetes fails to gather the same attention that cancer or any other scary virus may. Perhaps this is because of how common type 2 diabetes is. Typically type 2 diabetes developed in adults over the age of 40 but alarmingly, it is increasing in children and younger people.
Due to our modern lifestyles of more food and little exercise, the process speeds up considerable. People, who may develop this disease in their 60's wind up developing the disease much earlier, sometimes, in childhood or in their teens. While anyone can develop diabetes, there are some people who carry a higher risk, particularly individuals who are obese. We can divide the type 2 diabetes risks into two categories: controllable and uncontrollable risks.
Risk factors that cannot be controlled include:
- Family history. If a member of your immediate family has type 2 diabetes, the chances of developing the disease are greater
- Age. Type 2 diabetes risks increase with age. Historically, type 2 diabetes usually develops after you hit 40 but its occurrence is rising amongst children.
- Race & ethnicity. Hispanics, Asians, African Americans, Native Americans and Pacific Islands carry higher risk than white for this disease
- Having diabetes during pregnancy (Gestational diabetes) or delivering a baby weighing more than 9lb (4kg).
- Low birth weight. Type 2 diabetes risks are higher for people who weighed less than 5.5lb (2.5kg) when born
Controllable risk factors include the following:
- Obesity. If your body mass index (BMI) is higher than 25, you carry a higher risk of type 2 diabetes.
- Inactivity (Exercising less than 3 times a week )
- Poor nutrition
- Hypertension. High blood pressure increases the type 2 diabetes risks.
- Abnormal cholesterol levels. Having HDL/good cholesterol less than 35 md/dL or triglyceride levels higher than 250 mg/dL
Other factors which can increase the chances of type 2 include:
- Polycystic ovary syndrome (PCOS), an imbalance in hormones which interferes with the normal ovulation.
- Metabolic syndrome. A group of conditions which relate to the body's metabolism.
- Acanthosis nigricans (having thickened, dark skin around your armpits or neck)
About the Author
Type 1 Diabetes in Pregnancy
|
|
Obesity and Type 2 Diabetes ... |
|
|
Obesity and Type 2 Diabetes [HD] ... |
|
|
Diabetes Rising: How a Rare Disease Became a Modern Pandemic, and What to Do About It $26.95 Now in paperback—the controversial expose of the causes and treatments of diabetes, revised and updated. “Diabetes Rising takes on the fastest-growing disease in history with a take-no-prisoner’s attitude. Not willing to live with the enemy, Dan Hurley wants to kill it in its crib.”—Chris Matthews, Host of MSNBC’s Hardball with Chris Matthews In Diabetes Rising, inves... |
|
|
Metabolic Risk for Cardiovascular Disease (American Heart Association Clinical Series) $110.35 The relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes.This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabol... |
|
|
The Epidemiology of Pediatric and Adolescent Diabetes $109.95 As the incidence of childhood obesity continues to dramatically increase, the emergence of type 2 and the increasing incidence of type 1 diabetes in young people demonstrate that childhood diabetes, like adult onset diabetes, is a complex and heterogeneous condition presenting new obstacles to the practicing clinician. Epidemiology of Pediatric and Adolescent Diabetes is the first source on the ma... |
|
|
Type 1 Diabetes in Adults (Book) $63.9 At a time of dramatic increases in the prevalence of obesity, it is appropriate that Type 2 diabetes has received a great deal of attention by the endocrinology community. Clearly, the management of insulin resistance and cardiovascular risk is a critical issue. However, it is important to also acknowledge and address Type 1 diabetes, whose prevalence is also increasing, and whose management remains complex. Currently it is estimated that 10-15% of those with diabetes carry the diagnosis of Type 1 diabetes, and frequently the diagnosis is not straightforward, as many clinicians recognize that more adults previously thought to have Type 2 diabetes actually have late-onset Type 1 diabetes (also termed latent autoimmune diabetes of the adult or LADA). Over the last decade tools for the management of Type 1 diabetes have also evolved; therefore, clinicians now have the opportunity to more closely replicate normal physiologic insulin secretion with either basal-bolus insulin therapy or continuous subcutaneous insulin infusions. While these advancements allow clinicians to manage patients with Type 1 diabetes better, they also add complexity to patient treatment. An updated text to address the concepts behind the recognition of new onset Type 1 diabetes in adults, the ongoing care of adults with established Type 1 diabetes, and future potential therapies and devices is warranted to review these issues for both endocrinologists and primary care providers with an interest in diabetes. As part of the Oxford American Endocrinology Library, this volume stands as a concise guide in the treatment of Type 1 Diabetes in adults. The authors briefly examine the classification and pathophysiology of Type 1 diabetes (including predication and prevention and LADA) and address management (blood glucose monitoring, insulin therapy, and Continuous Subcutaneous Insulin Infusion) and complications (Hyperglycemia, Retinocpathy, Nephropathy, Neuropathy, etc) of the disease. Finally |
|
|
Medical Management of Type 1 Diabetes (Paperback) $108.15 "Type 1 diabetes, formerly known as juvenile diabetes, is a complex disorder that requires a great deal of patient-guided self-care. In recent years, advances in diabetes treatment have dramatically shifted potential outcomes in the favor of the patient with diabetes. The challenge for health care professionals is to realize this potential through an individualized, flexible, and responsive treatment plan for patients with type 1 diabetes.Now in its sixth edition, Medical Management of Type 1 Diabetes offers health care providers the newest information and guidelines for the treatment of type 1 diabetes. Built on the foundation of multiple daily insulin injections and insulin pump therapy, this book guides health care providers in helping their patients continually strive for optimal blood glucose control. This new edition focuses on the latest molecular advances, new treatment methods, recent clinical trials, and the American Diabetes Association`s Standards of Care. Key topics also include new insulinsand administration protocols, advanced carbohydrate counting, and emphasis on continuing patient education.Individual sections address all of the topics in managing type 1 diabetes, including:Diagnosis and Classification/PathogenesisDiabetes Standards and EducationTools of TherapySpecial SituationsPsychosocial Factors Affecting Adherence, Quality of Life, and Well-BeingComplicationsEdited by Dr. Francine Kaufman, a widely recognized expert in the treatment of diabetes and of insulin therapy, and guided by the recognized authority of the American Diabetes Association`s Standards of Care, Medical Management of Type 1 Diabetes is an essential addition to any clinician`s library for the treatment and understanding of type 1 diabetes"--Provided by publisher. |
|
|
Practical Diabetes Care (Paperback) $96.73 Diabetes is the catalyst for a whole host of chronic complications that can appear as a result of the disease, such as: diabetic retinopathy, diabetic neuropathy, foot ulcers, kidney failure, and an increased risk of heart disease and stroke. Diabetes management is changing rapidly, and powerful new agents, including some that may modify the natural history of diabetes and its complications, continue to be introduced, as both Type 1 and Type 2 diabetes increase in prevalence and impact worldwide. This brief guide summarizes the specific information needed for clinical treatment of diabetic patients. |
